Fei Li Kuang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fei Li Kuang has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Paneez Khoury
Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
5 shared publicationsAmy D. Klion
Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4 shared publicationsThomas Brown
Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4 shared publications- Amy D. Klion
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
3 shared publications - Ikuo Hirano
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
2 shared publications JeanAnne M. Ware
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (4) , 100722
Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes
- 1 May 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (4) , 100722
Open AccessCirculating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes
- Open Access
- 28 August 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (21)
Cellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome
With cell-by-cell mapping, we charted immune cells in lymphocytic-variant hypereosinophilic syndrome, found drug targets, and showed targeted therapy removed disease-causing cells and eased symptoms.
- 28 August 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (21)
Open AccessCellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome
With cell-by-cell mapping, we charted immune cells in lymphocytic-variant hypereosinophilic syndrome, found drug targets, and showed targeted therapy removed disease-causing cells and eased symptoms.
- 20 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1421-1429.e2
Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome
- 20 March 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (6) , 1421-1429.e2
Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome
- 30 August 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 116 (6) , 1324-1333
Advancing toward a unified eosinophil signature from transcriptional profiling
Eosinophils are granulocytes that can accumulate in increased numbers in tissues and/or peripheral blood in disease. Phenotyping of eosinophils in health and disease has the potential to improve the precision of diagnosis and choice of therapies for eosinophilic-associated diseases. Transcriptional profiling of eosinophils has been plagued by cell fragility and difficulty isolating high-quality RNA. With several technological advances, single-cell RNA sequencing has become possible with eosinophils, at least from mice, while bulk RNA sequencing and microarrays have been performed in both murine and human samples. Anticipating more eosinophil transcriptional profiles in the coming years, we provide a summary of prior studies conducted on mouse and human eosinophils in blood and tissue, with a discussion of the advantages and potential pitfalls of various approaches. Common technical standards in studying eosinophil biology would help advance the field and make cross-study comparisons possible. Knowledge gaps and opportunities include identifying a minimal set of genes that define the eosinophil lineage, comparative studies between active disease and remission vs. homeostasis or development, especially in humans, and a comprehensive comparison between murine and human eosinophils at the transcriptional level. Characterizing such transcriptional patterns will be important to understanding the complex and diverse roles of eosinophils in both health and disease.
- 30 August 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 116 (6) , 1324-1333
Advancing toward a unified eosinophil signature from transcriptional profiling
Eosinophils are granulocytes that can accumulate in increased numbers in tissues and/or peripheral blood in disease. Phenotyping of eosinophils in health and disease has the potential to improve the precision of diagnosis and choice of therapies for eosinophilic-associated diseases. Transcriptional profiling of eosinophils has been plagued by cell fragility and difficulty isolating high-quality RNA. With several technological advances, single-cell RNA sequencing has become possible with eosinophils, at least from mice, while bulk RNA sequencing and microarrays have been performed in both murine and human samples. Anticipating more eosinophil transcriptional profiles in the coming years, we provide a summary of prior studies conducted on mouse and human eosinophils in blood and tissue, with a discussion of the advantages and potential pitfalls of various approaches. Common technical standards in studying eosinophil biology would help advance the field and make cross-study comparisons possible. Knowledge gaps and opportunities include identifying a minimal set of genes that define the eosinophil lineage, comparative studies between active disease and remission vs. homeostasis or development, especially in humans, and a comprehensive comparison between murine and human eosinophils at the transcriptional level. Characterizing such transcriptional patterns will be important to understanding the complex and diverse roles of eosinophils in both health and disease.
- Open Access
- 9 September 2023
- Published by Elsevier in Gastroenterology
- Vol. 166 (1) , 1-10
Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis
- 9 September 2023
- Published by Elsevier in Gastroenterology
- Vol. 166 (1) , 1-10
Open AccessAscending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis
- 26 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (9) , 2666-2671
Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies
- 26 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (9) , 2666-2671
Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies
- 24 July 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (10) , 1031-1040
Distinct CRTH2+CD161+ (peTh2) memory CD4+ T‐cell cytokine profiles in food allergy and eosinophilic gastrointestinal disorders
Introduction: Although IgE‐mediated food allergy (FA) and eosinophilic gastrointestinal disorders (EGID) are clinically distinct and treated differently, pathogenic effector Th2 (peTh2) cells are implicated in the pathogenesis of both FA and EGID. The aim of this study was to better characterize peTh2 cells in the context of FA and EGID and the overlap between these two conditions.Methods: Peripheral blood peTh2 cells (CD3+CD4+CD27−CD49d+CRTH2+CD161+) were profiled by intracellular cytokine flow cytometry in the following patient cohorts: patients with FA alone (n = 8), FA and food‐triggered EGID (EGID+FA+FT, n = 7), food‐triggered EGID alone (EGID+FT, n = 7), EGID without FA or specific food triggers (ONLY_EGID, n = 9), and healthy volunteers (HV, n = 7). Overnight peripheral blood mononuclear cell (PBMC) culture supernatants were assessed for cytokine production by multiplex analysis.Results: CRTH2+CD161+ (peTh2) memory CD4+ T cells were significantly increased in both patients with FA and those with ALL_EGID (inclusive of EGID+FA+FT, EGID+FT and ONLY_EGID) when compared to HV. However, ALL_EGID patients, particularly those with EGID+FA+FT, had significantly elevated IL‐5+IL‐13+ peTh2 cells, whereas FA patients had significantly elevated IFN‐γ or IL‐17A‐expressing peTh2 cells. This finding was supported by increased spontaneous IL‐5 and IL‐13 production in overnight cultures of PBMC from EGID+FA+FT patients compared to spontaneous IL‐10 and IFN‐γ production by PBMC from FA patients. FA patients had increased IL‐9, IL‐10, IL‐17A, and IFN‐γ production in overnight cultures of stimulated PBMC.Conclusions: EGID and IgE‐mediated FA share a common cell subtype defined by specific surface markers and termed CRTH2+CD161+ (peTh2) memory CD4+ T cells. However, the cytokine profiles of these CRTH2+CD161+ (peTh2) memory CD4+ T cells are markedly different between the two disorders.
- 24 July 2023
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 53 (10) , 1031-1040
Distinct CRTH2+CD161+ (peTh2) memory CD4+ T‐cell cytokine profiles in food allergy and eosinophilic gastrointestinal disorders
Introduction: Although IgE‐mediated food allergy (FA) and eosinophilic gastrointestinal disorders (EGID) are clinically distinct and treated differently, pathogenic effector Th2 (peTh2) cells are implicated in the pathogenesis of both FA and EGID. The aim of this study was to better characterize peTh2 cells in the context of FA and EGID and the overlap between these two conditions.Methods: Peripheral blood peTh2 cells (CD3+CD4+CD27−CD49d+CRTH2+CD161+) were profiled by intracellular cytokine flow cytometry in the following patient cohorts: patients with FA alone (n = 8), FA and food‐triggered EGID (EGID+FA+FT, n = 7), food‐triggered EGID alone (EGID+FT, n = 7), EGID without FA or specific food triggers (ONLY_EGID, n = 9), and healthy volunteers (HV, n = 7). Overnight peripheral blood mononuclear cell (PBMC) culture supernatants were assessed for cytokine production by multiplex analysis.Results: CRTH2+CD161+ (peTh2) memory CD4+ T cells were significantly increased in both patients with FA and those with ALL_EGID (inclusive of EGID+FA+FT, EGID+FT and ONLY_EGID) when compared to HV. However, ALL_EGID patients, particularly those with EGID+FA+FT, had significantly elevated IL‐5+IL‐13+ peTh2 cells, whereas FA patients had significantly elevated IFN‐γ or IL‐17A‐expressing peTh2 cells. This finding was supported by increased spontaneous IL‐5 and IL‐13 production in overnight cultures of PBMC from EGID+FA+FT patients compared to spontaneous IL‐10 and IFN‐γ production by PBMC from FA patients. FA patients had increased IL‐9, IL‐10, IL‐17A, and IFN‐γ production in overnight cultures of stimulated PBMC.Conclusions: EGID and IgE‐mediated FA share a common cell subtype defined by specific surface markers and termed CRTH2+CD161+ (peTh2) memory CD4+ T cells. However, the cytokine profiles of these CRTH2+CD161+ (peTh2) memory CD4+ T cells are markedly different between the two disorders.
- Open Access
Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire
Background: Eosinophilic esophagitis (EoE) involves a chronic immune‐mediated response to dietary antigens. Recent work identifies T‐cell clonality in children with EoE, however, it is unknown whether this is true in adults or whether there is a restricted food‐specific T‐cell repertoire. We sought to confirm T‐cell receptor (TCR) clonality in EoE and assess for differences with specific food triggers.Methods: Bulk TCR sequencing was performed on mRNA isolated from esophageal biopsies obtained from adults and children with EoE (n = 15) who had food triggers confirmed by endoscopic evaluation. Non‐EoE adult and pediatric controls (n = 10) were included. Differences in TCR clonality by disease and treatment status were assessed. Shared and similar V‐J‐CDR3s were assessed based on specific food triggers.Results: Active EoE biopsies from children but not adults displayed decreased unique TCRα/β clonotypes and increased relative abundance of TCRs comprising >1% of the total compared to non‐EoE controls and paired inactive EoE samples. Among patients in which baseline, post diet elimination, and food trigger reintroduction samples (n = 6) were obtained, we observed ~1% of TCRs were shared only between pre‐diet elimination and trigger reintroduction. Patients with a shared EoE trigger (milk) had a greater degree of shared and similar TCRs compared to patients with differing triggers (seafood, wheat, egg, soy).Conclusion: We confirmed relative clonality in children but not adults with active EoE and identified potential food‐specific TCRs, particularly for milk‐triggered EoE. Further studies are needed to better identify the broad TCR repertoire relevant to food triggers.
Open AccessBulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire
Background: Eosinophilic esophagitis (EoE) involves a chronic immune‐mediated response to dietary antigens. Recent work identifies T‐cell clonality in children with EoE, however, it is unknown whether this is true in adults or whether there is a restricted food‐specific T‐cell repertoire. We sought to confirm T‐cell receptor (TCR) clonality in EoE and assess for differences with specific food triggers.Methods: Bulk TCR sequencing was performed on mRNA isolated from esophageal biopsies obtained from adults and children with EoE (n = 15) who had food triggers confirmed by endoscopic evaluation. Non‐EoE adult and pediatric controls (n = 10) were included. Differences in TCR clonality by disease and treatment status were assessed. Shared and similar V‐J‐CDR3s were assessed based on specific food triggers.Results: Active EoE biopsies from children but not adults displayed decreased unique TCRα/β clonotypes and increased relative abundance of TCRs comprising >1% of the total compared to non‐EoE controls and paired inactive EoE samples. Among patients in which baseline, post diet elimination, and food trigger reintroduction samples (n = 6) were obtained, we observed ~1% of TCRs were shared only between pre‐diet elimination and trigger reintroduction. Patients with a shared EoE trigger (milk) had a greater degree of shared and similar TCRs compared to patients with differing triggers (seafood, wheat, egg, soy).Conclusion: We confirmed relative clonality in children but not adults with active EoE and identified potential food‐specific TCRs, particularly for milk‐triggered EoE. Further studies are needed to better identify the broad TCR repertoire relevant to food triggers.
- 10 March 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (6) , 1598-1605.e2
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease
- 10 March 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (6) , 1598-1605.e2
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease
- Open Access
- 1 January 2022
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Respiratory & Pulmonary Diseases
- Vol. 7 (2)
Dexpramipexole: A Potential Non-biologic Alternative for Patients with Eosinophilic Asthma?
Dexpramipexole offers a potential non-biologic option for patients with eosinophilic asthma in that it lowers blood eosinophil count and improves lung function parameters. However, longer-term studies in patients treated by reducing blood or tissue eosinophils, whether through biologics or oral therapies, are needed to better understand the role of the eosinophil in human biology and disease pathogenesis and to better delineate the clinical efficacy of Dexpramizole in asthma.
- 1 January 2022
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Respiratory & Pulmonary Diseases
- Vol. 7 (2)
Open AccessDexpramipexole: A Potential Non-biologic Alternative for Patients with Eosinophilic Asthma?
Dexpramipexole offers a potential non-biologic option for patients with eosinophilic asthma in that it lowers blood eosinophil count and improves lung function parameters. However, longer-term studies in patients treated by reducing blood or tissue eosinophils, whether through biologics or oral therapies, are needed to better understand the role of the eosinophil in human biology and disease pathogenesis and to better delineate the clinical efficacy of Dexpramizole in asthma.